Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes
Dennis Rottlaender, … , Gerd Heusch, Uta C. Hoppe
Dennis Rottlaender, … , Gerd Heusch, Uta C. Hoppe
Published April 1, 2010
Citation Information: J Clin Invest. 2010;120(5):1441-1453. https://doi.org/10.1172/JCI40927.
View: Text | PDF | Retraction
Research Article Cardiology

Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes

  • Text
  • PDF
Abstract

Potassium (K+) channels in the inner mitochondrial membrane influence cell function and survival. Increasing evidence indicates that multiple signaling pathways and pharmacological actions converge on mitochondrial ATP-sensitive K+ (mitoKATP) channels and PKC to confer cytoprotection against necrotic and apoptotic cell injury. However, the molecular structure of mitoKATP channels remains unresolved, and the mitochondrial phosphoprotein(s) that mediate cytoprotection by PKC remain to be determined. As mice deficient in the main sarcolemmal gap junction protein connexin 43 (Cx43) lack this cytoprotection, we set out to investigate a possible link among mitochondrial Cx43, mitoKATP channel function, and PKC activation. By patch-clamping the inner membrane of subsarcolemmal murine cardiac mitochondria, we found that genetic Cx43 deficiency, pharmacological connexin inhibition by carbenoxolone, and Cx43 blockade by the mimetic peptide 43GAP27 each substantially reduced diazoxide-mediated stimulation of mitoKATP channels. Suppression of mitochondrial Cx43 inhibited mitoKATP channel activation by PKC. MitoKATP channels of interfibrillar mitochondria, which do not contain any detectable Cx43, were insensitive to both PKC activation and diazoxide, further demonstrating the role of Cx43 in mitoKATP channel stimulation and the compartmentation of mitochondria in cell signaling. Our results define a role for mitochondrial Cx43 in protecting cardiac cells from death and provide a link between cytoprotective stimuli and mitoKATP channel opening, making Cx43 an attractive therapeutic target for protection against cell injury.

Authors

Dennis Rottlaender, Kerstin Boengler, Martin Wolny, Guido Michels, Jeannette Endres-Becker, Lukas J. Motloch, Astrid Schwaiger, Astrid Buechert, Rainer Schulz, Gerd Heusch, Uta C. Hoppe

×

Figure 6

MitoKATP channel activity of interfibrillar mitochondria is insensitive to PKC and diazoxide (100 μM) stimulation.

Options: View larger image (or click on image) Download as PowerPoint
MitoKATP channel activity of interfibrillar mitochondria is insensitive ...
(A) MitoKATP single-channel current (at –60 mV) of interfibrillar mitochondria (left), which was not activated by diazoxide (middle) but was inhibited by glibenclamide (right). (B) Mean values of mitoKATP channel open probability (Po,total; top left), Ipeak (top right), mean open time (bottom left), and mean closed time (bottom, right) of interfibrillar mitochondria in the absence and presence of diazoxide, PMA, glibenclamide, and MgATP, as indicated; n values are shown in parentheses. *P < 0.05 versus control. Single-channel amplitude as a function of test potentials. (C) Slope conductance (14.1 ± 0.5 pS, n = 6) of interfibrillar mitoKATP channels determined by linear regression in individual experiments was similar to that of subsarcolemmal mitochondria (Figure 3B). (D) MitoKATP single-channel activity of interfibrillar mitochondria (IFM) was not activated by PKC stimulation with 2 μM PMA (top). Baseline activity was inhibited by 100 μM MgATP (bottom). Voltages are indicated. (E) Amplitude histogram of interfibrillar mitoKATP current under baseline conditions revealed a mean Iunitary of –0.85 ± 0.04 pA (n = 12).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts